Financial Services

Despite the turbulence of recent years there is no doubt that the UK remains a major hub of international finance and will do so for the foreseeable future.

The regulatory agenda in the aftermath of the GFC looks to have been reasonably successfully addressed, with most banks now better capitalised, although 2020 still leaves an important Brexit hurdle with implications particularly for those with activity in continental Europe.

The overall FS landscape remains one of shifting dynamics, with opportunities continuing to present themselves for those who can offer better customer acquisition and retention and/or improved cost control and efficiency. By focusing on innovation or specialist expertise, niche operators are still able to penetrate consumer and SME markets, once almost exclusively the domain of the larger incumbents.

Cavendish has a strong record in selling a whole range of entrepreneurial FS businesses including those dedicated to consumer finance, specialist lending, FX and debt collection. Our team is in regular contact with major UK and overseas FS companies as well as private equity houses which focus on the FS sector. We understand well their acquisition aspirations and, in the case of corporates, their future strategic plans.

CASE STUDY

Cavendish advised on the sale of Tempcover Limited

Cavendish Corporate Finance is pleased to announce that it has advised on the sale of Tempcover Limited (“Tempcover”), the UK’s leading provider of easy-to-understand, direct to consumer, short-term motor insurance products. The sale was concluded to Connection Capital LLP (“Connection”).

Recent deals for Financial Services

OUR TEAM

Meet our experts

Cavendish’s success is based on the wealth of experience of our people. We have a team of professionals with expertise across a wide variety of sectors, deal sizes, and transaction types.

Duncan Chandler

Partner & Head of Financial Services

View profile

Peter Gray

Partner

View profile

Our latest news

Selling Your Business: How to attract the best buyer
In the final part of our series on exiting, we look at the four most common types of buyer, the processes involved for each one, and discuss...
Global pharma and biotech’s fight against COVID-19
Perhaps it’s time for some good news. First of all, just today biotherapeutics developer Avacta has announced its partnership with Cytiva,...
How are Private Equity firms reacting to the Covid-19 crisis?
The relentless progress of Covid-19 is pummeling life and business in the UK in a way that hasn’t been seen since World War II. The health...

What can we help you achieve?

Get in touch

Thank you. We will be in touch soon

There was an error with the form. Please check and try again.